AmeriCann, Inc. Quarterly Nonoperating Income (Expense) in USD from Q4 2016 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
AmeriCann, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q4 2016 to Q3 2024.
  • AmeriCann, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$131K, a 15.1% increase year-over-year.
  • AmeriCann, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$509K, a 28% increase year-over-year.
  • AmeriCann, Inc. annual Nonoperating Income (Expense) for 2024 was -$509K, a 28% increase from 2023.
  • AmeriCann, Inc. annual Nonoperating Income (Expense) for 2023 was -$706K, a 7.69% decline from 2022.
  • AmeriCann, Inc. annual Nonoperating Income (Expense) for 2022 was -$656K, a 27.7% increase from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$509K -$131K +$23.2K +15.1% Jul 1, 2024 Sep 30, 2024 10-K 2025-01-15
Q2 2024 -$532K -$126K +$59.1K +32% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 -$591K -$121K +$61.4K +33.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$652K -$131K +$54.1K +29.2% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-14
Q3 2023 -$706K -$154K +$12.9K +7.71% Jul 1, 2023 Sep 30, 2023 10-K 2025-01-15
Q2 2023 -$719K -$185K -$20.9K -12.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 -$698K -$183K -$21.7K -13.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$677K -$185K -$20.8K -12.6% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-14
Q3 2022 -$656K -$167K +$48.3K +22.5% Jul 1, 2022 Sep 30, 2022 10-K 2023-12-22
Q2 2022 -$704K -$164K +$60.7K +27% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$765K -$161K +$107K +39.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$872K -$164K +$35.3K +17.7% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-14
Q3 2021 -$907K -$215K -$5.7K -2.72% Jul 1, 2021 Sep 30, 2021 10-K 2022-12-29
Q2 2021 -$901K -$224K -$26.5K -13.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$875K -$268K -$352K -419% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$523K -$200K -$408 -0.21% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-14
Q3 2020 -$523K -$210K +$1.04M +83.2% Jul 1, 2020 Sep 30, 2020 10-K 2021-12-06
Q2 2020 -$1.56M -$198K -$152K -333% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$1.41M $84K +$121K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$1.53M -$199K -$18.7K -10.3% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-16
Q3 2019 -$1.51M -$1.25M -$927K -288% Jul 1, 2019 Sep 30, 2019 10-K 2020-12-21
Q2 2019 -$585K -$45.7K +$806K +94.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 -$1.39M -$37.3K +$406K +91.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 -$1.8M -$181K +$606K +77% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-19
Q3 2018 -$2.4M -$321K -$247K -334% Jul 1, 2018 Sep 30, 2018 10-K 2020-01-14
Q2 2018 -$2.16M -$852K -$771K -951% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-19
Q1 2018 -$1.39M -$444K -$352K -383% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-20
Q4 2017 -$1.03M -$787K -$699K -800% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-19
Q3 2017 -$334K -$74K Jul 1, 2017 Sep 30, 2017 10-K 2019-01-15
Q2 2017 -$81K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$91.8K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$87.4K Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.